Companies / Taysha Gene Therapies, Inc. / Activity
Activity — Taysha Gene Therapies, Inc.
20 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Nagendran Sukumar Executive | Sell | Common Stock | $942.0K | -200K -16.58% | 1,006,439 0.31% of shares | medium |
| Jan 23, 2026 | Nolan Sean P. CEO | Sell | Common Stock | $649.7K | -137K -4.43% | 2,949,569 0.91% of shares | medium |
| Jan 23, 2026 | Nagendran Sukumar Executive | Sell | Common Stock | $423.4K | -89K -6.22% | 1,344,307 0.41% of shares | medium |
| Jan 23, 2026 | Alam Kamran Executive | Sell | Common Stock | $375.1K | -79K -5.11% | 1,467,635 0.45% of shares | medium |
| Jan 26, 2026 | Nolan Sean P. CEO | Sell | Common Stock | $190.4K | -41K -1.40% | 2,908,257 0.89% of shares | medium |
| Jan 12, 2026 | Nagendran Sukumar Executive | Exercise | Common Stock | $151.6K | +89K +7.93% | 1,206,439 0.37% of shares | low |
| Jan 26, 2026 | Nagendran Sukumar Executive | Sell | Common Stock | $124.1K | -27K -2.00% | 1,317,389 0.40% of shares | medium |
| Jan 26, 2026 | Alam Kamran Executive | Sell | Common Stock | $109.9K | -24K -1.63% | 1,443,786 0.44% of shares | medium |
| Jan 12, 2026 | Nagendran Sukumar Executive | Exercise | Common Stock | $77.8K | +111K +11.06% | 1,117,763 0.34% of shares | low |
| Feb 4, 2026 | Alam Kamran Executive | Sell | Common Stock | $7.5K | -2K -0.11% | 1,442,131 0.44% of shares | low |
| Jun 1, 2026 | Donenberg Phillip B. Director | Grant | Common Stock | $0 | +21K +9.70% | 241,289 0.07% of shares | low |
| Jan 12, 2026 | Alam Kamran Executive | Grant | Common Stock | $0 | +359K +30.23% | 1,546,603 0.47% of shares | low |
| Jan 12, 2026 | Nagendran Sukumar Executive | Grant | Common Stock | $0 | +427K +42.43% | 1,433,439 0.44% of shares | low |
| Jan 12, 2026 | Nolan Sean P. CEO | Grant | Common Stock | $0 | +1.0M +48.50% | 3,086,358 0.95% of shares | low |
| Jun 1, 2026 | Donenberg Phillip B. Director | Grant | Stock Option (right to buy) | — | +43K | 42,671 0.01% of shares | low |
| Jan 12, 2026 | Alam Kamran Executive | Grant | Employee Stock Option (right to buy) | — | +231K | 231,000 0.07% of shares | low |
| Jan 12, 2026 | Nagendran Sukumar Executive | Grant | Employee Stock Option (right to buy) | — | +274K | 274,000 0.08% of shares | low |
| Jan 12, 2026 | Nagendran Sukumar Executive | Exercise | Employee Stock Option (right to buy) | — | -89K -15.73% | 474,941 0.15% of shares | low |
| Jan 12, 2026 | Nagendran Sukumar Executive | Exercise | Employee Stock Option (right to buy) | — | -111K -49.99% | 111,359 0.03% of shares | low |
| Jan 12, 2026 | Nolan Sean P. CEO | Grant | Employee Stock Option (right to buy) | — | +648K | 648,000 0.20% of shares | low |